Atlas Trials

Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy

Clinical trial NCT00540384 · COMPLETED

Trial details

NCT number
NCT00540384
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AnemiaSolid Tumors
Start date
1999-07-01
Primary completion
2002-03-01
Enrollment
405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.